Skip to main content
Article thumbnail
Location of Repository

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa

By Satoshi Inoue, Joan Riley, Timothy W. Gant, Martin J.S. Dyer and Gerald M. Cohen


This is the authors' final draft of the paper published as Leukemia 2007, 21(8), pp.1773-82. The published version is available via doi:10.1038/sj.leu.2404760.Several histone deacetylase inhibitors (HDACi), which have recently entered early\ud clinical trials, exert their anti-cancer activity in part through the induction of apoptosis although the precise mechanism of this induction is not known. Induction of apoptosis by structurally diverse HDACi in primary cells from patients with chronic\ud lymphocytic leukemia (CLL) and different leukemic cell lines was mediated by the\ud Bcl-2 regulated intrinsic pathway and demonstrated a requirement for de novo protein synthesis. A marked time dependent induction of the pro-apoptotic BH3-only proteins, Bim, Noxa and Bmf was observed, which preceded the induction of apoptosis. A key role for both Bim and Noxa was proposed in HDACi-mediated apoptosis based on our\ud findings that siRNA for Bim and Noxa but not Bmf largely prevented the HDACi induced\ud loss in mitochondrial membrane potential, caspase processing and phosphatidylserine externalization. Noxa, induced by HDACi, in CLL cells and tumor cell lines, bound extensively to Mcl-1, a major anti-apoptotic Bcl-2 family member present in CLL cells. Our data strongly suggests that HDACi induce apoptosis primarily through inactivation of anti-apoptotic Bcl-2 family members by increases in Bim and Noxa and highlights these increases as a potential clinical target for CLL/lymphoma therapy

Publisher: Nature Publishing Group
Year: 2007
DOI identifier: 10.1038/sj.leu.2404760.
OAI identifier:

Suggested articles


  1. (1998). a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell doi
  2. (2000). a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science doi
  3. (2005). Chronic lymphocytic leukemia cells display p53-dependent druginduced Puma upregulation. Leukemia doi
  4. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res doi
  5. (2005). E1A activates transcription of p73 and Noxa to induce apoptosis. doi
  6. (1998). Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood
  7. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science doi
  8. (2005). Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res doi
  9. (1997). Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science doi
  10. (2003). The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. doi
  11. (2006). The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood doi
  12. (2004). Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.